Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Viral features of lamivudine resistant hepatitis B genotypes A and D.

Hepatology (Baltimore, Md.) - 1 Jan 2004

Zöllner Bernhard, Petersen Jörg, Puchhammer-Stöckl Elisabeth, Kletzmayr Josef, Sterneck Martina, Fischer Lutz, Schröter Matthias, Laufs Rainer, Feucht Heinz-Hubert

Abstract excerpt

Viral differences among lamivudine resistant hepatitis B (HBV) genotypes have not been yet investigated. Therefore, we analyzed the characteristics of these viral strains in vivo. Forty-one patients carrying lamivudine resistant HBV were enrolled. Twenty-six patients (63%) carried resistant HBV genotype A (group A) and 15 patients (37%) carried resistant HBV genotype D (group D). The rate of reverse transcriptase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Hepatitis B, Chronic

Share to Hepatitis B Core Antigens

Share to Hepatitis B virus

Share to Lamivudine

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 14752821
DOI: 10.1002/hep.20016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Viral features of lamivudine resistant hepatitis B genotypes A and D.PMID 14752821Read ↗

Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains.Semantic proximity Read ↗

Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil.Semantic proximity Read ↗

Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern.Semantic proximity Read ↗

Dynamics of Hepatitis B Virus Resistance to LamivudineSemantic proximity Read ↗

Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.Semantic proximity Read ↗

The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes.Semantic proximity Read ↗

Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains.Semantic proximity Read ↗

Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience.Semantic proximity Read ↗

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.Semantic proximity Read ↗

Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes.Semantic proximity Read ↗

Lamivudine monotherapy in chronic hepatitis B patients from the Indian subcontinent: antiviral resistance mutations and predictive factors of treatment response.Semantic proximity Read ↗

Comparison of replication competence of wild-type and lamivudine-resistant hepatitis B virus isolates from a chronic hepatitis B patient.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.